I2Pure
I2Pure is a healthcare technology company dedicated to advancing health and biosafety by preventing infections and disease through its patented, non-toxic molecular iodine platform. Founded in 2019 by military veterans, the company focuses on harnessing the natural antimicrobial power of molecular iodine to fight pathogens, reduce infection risks, and develop innovative products across healthcare, water disinfection, food safety, animal health, and industrial cleaning. With a mission to prevent pathogenic threats globally, I2Pure leverages its scientific expertise and proprietary technology to create effective, safe, and affordable iodine-based solutions for a wide range of applications.
Industries
Nr. of Employees
small (1-50)
Patents
High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
US-12485141-B2
View Details
High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
US-12485141-B2
View DetailsProducts
Topical antiseptic and wound-care formulations containing stabilized molecular iodine
Calibrated topical formulations (ointments, lotions, ointments/serums) that deliver free molecular iodine for persistent antimicrobial activity, wound irrigation, dermal regeneration and reduced inflammation.
Iodinized coatings and device-surface treatments
Polymer and coating solutions that incorporate stabilized molecular iodine to provide persistent antimicrobial activity on catheters, implants, dressings and other medical-device surfaces.
Slow-release iodine water-disinfection media and filter cores
Filter media and center-core technologies that slowly release free molecular iodine to disinfect water and prevent biofilm growth in water delivery systems.
Surface disinfectant sprays and sterilants containing free molecular iodine
Non-caustic surface disinfectant formulations and device sterilants formulated to deliver free molecular iodine for broad-spectrum activity against bacteria, fungi and viruses without leaving harmful residues.
I2·Blue
A revolutionary FDA-registered iodine topical antiseptic soak featuring a 1,400 ppm I2 reservoir, offering high molecular iodine concentration and superior antimicrobial efficacy.
I2Pure Molecular Iodine Technology
Revolutionary antimicrobial technology delivering 50-2,500 ppm of free molecular iodine for rapid, broad-spectrum pathogen elimination without pathogenic resistance.
Topical antiseptic and wound-care formulations containing stabilized molecular iodine
Calibrated topical formulations (ointments, lotions, ointments/serums) that deliver free molecular iodine for persistent antimicrobial activity, wound irrigation, dermal regeneration and reduced inflammation.
Iodinized coatings and device-surface treatments
Polymer and coating solutions that incorporate stabilized molecular iodine to provide persistent antimicrobial activity on catheters, implants, dressings and other medical-device surfaces.
Slow-release iodine water-disinfection media and filter cores
Filter media and center-core technologies that slowly release free molecular iodine to disinfect water and prevent biofilm growth in water delivery systems.
Surface disinfectant sprays and sterilants containing free molecular iodine
Non-caustic surface disinfectant formulations and device sterilants formulated to deliver free molecular iodine for broad-spectrum activity against bacteria, fungi and viruses without leaving harmful residues.
I2·Blue
A revolutionary FDA-registered iodine topical antiseptic soak featuring a 1,400 ppm I2 reservoir, offering high molecular iodine concentration and superior antimicrobial efficacy.
I2Pure Molecular Iodine Technology
Revolutionary antimicrobial technology delivering 50-2,500 ppm of free molecular iodine for rapid, broad-spectrum pathogen elimination without pathogenic resistance.
Services
License or co-development agreements to embed stabilized molecular iodine formulations into third-party products (consumer, medical, water and industrial applications).
Coordination of preclinical studies and support for third-party standard testing (antimicrobial efficacy, cytotoxicity, sporicidal and virucide assays).
Technical support and integration services to embed slow-release iodine into filtration media and device cores for continuous water disinfection and biofilm control.
License or co-development agreements to embed stabilized molecular iodine formulations into third-party products (consumer, medical, water and industrial applications).
Coordination of preclinical studies and support for third-party standard testing (antimicrobial efficacy, cytotoxicity, sporicidal and virucide assays).
Technical support and integration services to embed slow-release iodine into filtration media and device cores for continuous water disinfection and biofilm control.
Expertise Areas
- Molecular iodine formulation and stabilization
- Topical and transdermal delivery
- Biofilm eradication and antimicrobial mechanisms
- Wound care and topical product development
Key Technologies
- Molecular iodine (I2) formulations
- Nanoencapsulation / iodine-infused nanoparticles
- Controlled-release / slow-release matrices
- Enzyme-catalyzed iodine regeneration
News & Updates
Partnership to bring new disinfection and antimicrobial products to market.
Recognition for Dr. Ilker Bayer for exceptional scholarly work.
Development of a new wound care product combining iodine technology and starch microspheres.
Development of shelf-stable, pH-neutral iodine solutions with improved efficacy.
License for iodine technology to enhance water filtration systems.
Partnership to create advanced water disinfection solutions.
Partnership to bring new disinfection and antimicrobial products to market.
Recognition for Dr. Ilker Bayer for exceptional scholarly work.
Development of a new wound care product combining iodine technology and starch microspheres.
Development of shelf-stable, pH-neutral iodine solutions with improved efficacy.
License for iodine technology to enhance water filtration systems.
Partnership to create advanced water disinfection solutions.